Active Biotech: Orphan Drug Designation for Tasquinimod in Myelofibrosis in the US

Redeye has a positive view of Active Biotech’s obtaining orphan drug status. We discuss the benefits in our comment.

RR

Richard Ramanius

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.